/Insulet%20Corporation%20insulin%20monitor-by%20Maria%20Wan%20via%20Shutterstock.jpg)
Insulet Corporation (PODD), headquartered in Acton, Massachusetts, operates as an innovative medical device company. Valued at $19.8 billion by market cap, the company develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes.
Shares of this insulin infusion systems maker have outperformed the broader market over the past year. PODD has gained 53.9% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 17.6%. In 2025, PODD stock is up 8.6%, surpassing the SPX’s 1.7% rise on a YTD basis.